moxalactam has been researched along with Bacterial Disease in 162 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 157 (96.91) | 18.7374 |
| 1990's | 5 (3.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C | 1 |
| Wilson, SE | 1 |
| Blum, M; Reers, B; Sulkowski, U; Winde, G | 1 |
| Rahman, M | 1 |
| Polk, RE | 1 |
| Barson, WJ; Nahata, MC | 1 |
| Denson, S; Kaplan, SL; Mason, EO; Pickering, LK; Ramos, OM | 1 |
| Barza, M; Murphy, TF | 1 |
| Aldridge, K; Derks, F; Faro, S; Janney, A; Marier, RL; Sanders, CV; Williams, W | 1 |
| Freimer, EH; Gilardi, GL; O'Donnell, ED; Raeder, R | 1 |
| De Jongh, CA; Finley, RS; Fortner, CL; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH | 1 |
| Matsumoto, K | 1 |
| Finegold, SM; Mathisen, GE; Meyer, RD; Thompson, JM | 1 |
| Daschner, FD; Mählmann, M; Metzger, M; Steffens, A | 1 |
| Klastersky, J; Lagast, H | 1 |
| Baltch, AL; Conroy, JV; Hammer, MC; Smith, RP; Sutphen, NT | 1 |
| Mielke, CH; Pakter, RL; Russell, TR; West, D | 1 |
| Gardner, S; Schreiber, M; Shulman, ST; Yogev, R | 1 |
| Feldman, WE; Hollins, M; Keyserling, H; Manning, N; Moffitt, S | 1 |
| Flynn, K; Goldmann, DA; Romagnoli, MF; Siber, GR | 1 |
| Carruthers, M; Cook, FV; Emmerman, J; Phair, JP; Reisberg, BE; Venezio, FR; Westenfelder, GO; Williams, JE | 1 |
| Aber, RC; Weitekamp, MR | 1 |
| Klastersky, J; Lagast, H; Meunier-Carpentier, F | 1 |
| Panwalker, AP; Rosenfeld, J | 1 |
| Fabricius, K; Hey, O; Nix, WA | 1 |
| Feigin, RD; Kaplan, SL; Kvernland, SJ; Loiselle, EM; Mason, EO | 1 |
| Evans, HE; Khan, AJ; Kumar, K; Patel, U; Quaye, G; Varghese, M | 1 |
| Daschner, FD; Pelz, K; Petersen, EE; Trennhäuser, M | 1 |
| Becker, TM; Freimer, EH; Raeder, R; Ribner, BS | 1 |
| Flournoy, DJ; Perrymann, F; Qadri, SM | 1 |
| Decazes, JM; Meulemans, A; Modai, J; Vittecoq, D; Wolff, M | 1 |
| Bal'a, F; Kantarjian, H; Osseiran, M; Tannir, N; Uwaydah, M | 1 |
| Aoyama, S; Cho, N; Doi, S; Fujimoto, A; Fukuda, T; Fukunaga, K; Haraguchi, H; Hayashi, S; Hirabayashi, K; Hiraoka, O; Hogaki, M; Ibaragi, K; Jujii, K; Kamigawara, Y; Kamiyoshi, S; Kashiwakura, T; Kobayashi, H; Kondo, I; Kunii, K; Kurasawa, S; Matsuda, S; Matsumoto, Y; Morimoto, N; Motomura, R; Muronosono, E; Nakai, T; Nakamura, H; Nakanishi, K; Ninomiya, K; Okada, E; Oniki, K; Ozawa, M; Risai, T; Saita, K; Sawaragi, I; Seki, K; Shimizu, H; Shimizu, T; Shirafuji, H; Shirakawa, K; Sugimoto, O; Tabei, T; Takase, Z; Tanno, M; Teramoto, C; Watanabe, K; Yamabe, T; Yamada, F; Yamamoto, K; Yuasa, M | 1 |
| Fiser, I; Klech, H | 1 |
| Geheber, CE; Kolb, L; Stone, HH | 1 |
| Gonzenbach, HR; Sonnabend, W | 1 |
| McCall, CE; Pegram, PS; Salzer, W | 1 |
| Luper, WE; Slonaker, CE | 1 |
| Pechère, JC | 1 |
| McCracken, GH; Nelson, JD; Shelton, S | 1 |
| Armengaud, M; Barza, M; Cherubin, CE; Corrado, ML; Landesman, SH; Shah, PM | 1 |
| Fekety, FR; McClatchey, KD; Pierson, CL; Schaberg, DR | 1 |
| Weinstein, AJ | 1 |
| Ehrenkranz, NJ; Hoffman, TA | 1 |
| Dunlop, WE; Fabian, TC; Stone, HH; Strom, PR | 1 |
| Marks, MI | 1 |
| Bégué, P; Brun, Y; Fleurette, J; Floret, D; Monnet, P; Safran, C | 1 |
| Coomans, D; Imbert, Y; Leng, B | 1 |
| Carbon, C | 1 |
| Dupeyron, JP; Peter, JD; Rigolot, JC | 1 |
| Acar, JF | 1 |
| Garzone, P; Lyon, J; Yu, VL | 1 |
| Endo, Y; Fujimoto, S; Hara, M; Kohi, F; Lai, M; Oda, Y; Ohmoto, E; Takahashi, I; Takaoka, K; Uchida, K | 1 |
| Bow, EJ; Chubb, H; Conly, JM; Louie, TJ; Ramotar, K | 1 |
| Calandra, GB; Grad, C; Hesney, M | 1 |
| Loock, CA; McCracken, GH; Schaad, UB; Thomas, ML | 1 |
| McCracken, GH; Schaad, UB; Thomas, ML; Threlkeld, N | 1 |
| Cunningham, FG; DePalma, RT; Hemsell, DL; Kappus, S; Nobles, B; Roark, M | 1 |
| Yu, VL | 1 |
| Malow, JB; Panwalker, AP; Porembski, PE; Ramirez, CA; Trager, GM; Zar, FA | 1 |
| Avent, CK; Cobbs, CG; Dismukes, WE; Elliott, AM; Livingston, WK | 1 |
| Jacobson, EJ; Nissenson, AR; Zahrowski, JJ | 1 |
| Nagamatsu, I; Ota, H; Takahashi, S; Takase, A; Togashi, K | 1 |
| Aoyama, R; Fujita, M; Haneda, S; Izumi, Y; Nagata, K | 1 |
| Chikaoka, H; Hirama, Y; Iwasaki, A; Nakazawa, S; Narita, A; Niino, K; Oka, S; Sato, H; Suzuki, H | 1 |
| Akita, H; Hara, N; Hirose, M; Hotta, M; Ichihashi, Y; Morikawa, Y; Nanri, S; Sunakawa, K; Tojo, M; Yamashita, N | 1 |
| Fujiwara, T; Haruta, T; Kobayashi, Y; Kuroki, S; Morikawa, Y; Okura, K | 1 |
| Arimasu, O; Fujii, R; Hiraiwa, M; Mashiko, J; Matsueda, Y; Meguro, H; Ozawa, S; Tohgo, T | 1 |
| Hachimori, K; Minamitani, M; Tomori, N | 1 |
| Hogaki, M; Matsumoto, Y; Muronosono, E | 1 |
| Iwata, Y; Kurosaki, T; Nakamura, A; Okimoto, U; Saito, N; Sato, T; Sugaya, N; Terashima, I; Uehara, S | 1 |
| Hoshina, H; Ichihashi, H; Ide, K; Yanagisawa, K | 1 |
| Hori, M; Kumagai, K; Kurosu, Y; Sugita, M; Takahashi, T; Toyonaga, Y | 1 |
| Inokuma, K; Iwai, N; Osuga, T; Sasaki, A; Taneda, Y | 1 |
| Hiromatsu, K; Nishimura, T; Tabuki, K; Takagi, M; Takashima, T | 1 |
| Crossley, KB; Rotschafer, J; Solliday, J; Tofte, RW | 1 |
| Lentino, JR; Moore, E; Rytel, MW | 1 |
| Afarian, J; Ehrlich, SL; Kass, EH; O'Brien, TF; Pennington, JE; Platt, R | 1 |
| Busuttil, RW; Kurtz, TO; Winston, DJ; Young, LS | 1 |
| Tally, FP | 1 |
| Levison, ME; Poporad, G; Romano, J; Snepar, R | 1 |
| Feigin, RD; Kaplan, SL; Mason, EO | 1 |
| Barnes, RC; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ; Young, LS | 1 |
| Aronoff, SC; Blumer, JL; Reed, MD | 1 |
| Douglas, GF; File, TM; Johnson, LA; Salstrom, SJ; Tan, JS | 1 |
| Eron, LJ; Goldenberg, RI; Hixon, DL; Park, CH; Poretz, DM | 1 |
| Ingall, D; Portman, M; Westenfelder, G; Yogev, R | 1 |
| Fett, DR; Silverman, CA; Yoshizumi, MO | 1 |
| Bouza, E; Guerrero, A; Hospital, JS; Loza, E; Martínez-Beltrán, J; Pérez del Rio, J; Rodríguez-Creixems, M | 1 |
| Chan-Lui, WY; Stroebel, AB; Yeung, CY | 1 |
| Ballard, JO; Joehl, RJ; Rasbach, DA; Sattler, FR; Weitekamp, MR | 1 |
| Bauman, DC; Beville, RB; Holmes, BJ; LaCorte, WF; Mogabgab, WJ; Pauling, B; Pollock, B | 1 |
| Maruyama, S; Oka, T; Sanae, N; Takimoto, M; Tsuchida, A; Yoshioka, H | 1 |
| Chikaoka, H; Hirama, Y; Nakazawa, S; Narita, A; Niino, K; Sato, H | 1 |
| Akita, H; Iwasaki, Y; Iwata, S; Kanemitsu, T; Nanri, S; Oikawa, T; Osano, M; Satoh, Y; Sunakawa, K; Tojo, M | 1 |
| Hori, M; Kitagawa, M; Kurosu, Y; Sugita, M; Toyonaga, Y | 1 |
| Iwai, N; Kawamura, M; Mizoguchi, F; Nakamura, H; Ozaki, T; Sasaki, A; Taneda, Y; Tauchi, N | 1 |
| Nishimura, T; Tabuki, K; Takashima, T | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Okura, K | 1 |
| Fujimoto, T; Ishimoto, K; Koga, T; Motohiro, T; Nishiyama, T; Sakata, Y; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, N | 1 |
| Akiyama, T; Cho, N; Fukunaga, K; Hidaka, T; Kawamura, E; Kunii, K; Nishimoto, S; Suzuki, H; Togo, M | 1 |
| Hamaya, K; Hasegawa, Y; Kanamoto, T; Ninomiya, K; Nishio, T; Niwa, K; Yoshimoto, T | 1 |
| Kanao, M; Okada, H; Yamamoto, T; Yasuda, J | 1 |
| Hujiwara, M; Komoto, Y; Miyoshi, T; Nakayama, M; Seto, M; Shirafuji, H; Takase, Z | 1 |
| Chin, C; Hayasaki, M; Iida, M; Itoh, K; Katoh, R; Kondoh, H; Noda, K; Ohsugi, S; Takada, Y; Yamada, Y | 1 |
| de Louvois, J; James, J; Mulhall, A | 1 |
| Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH | 1 |
| Smith, AL | 1 |
| Kumazawa, J; Shinagawa, N | 1 |
| Boas, J; Bruun, BG; Dombernowsky, P; Frimodt-Møller, N; Hansen, HH; Hansen, OP; Holländer, NH; Oturai, PS | 1 |
| Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Takada, M | 1 |
| Aparicio, M; Bouchet, JL; Bourdenx, JP; Demotes-Mainard, F; Dupoux, J; Potaux, L; Quentin, C; Vinçon, G | 1 |
| Kuzui, H; Murakami, T; Nishino, T; Obana, Y | 1 |
| Dabrowska, M; Gabryelewicz, A; Prokopowicz, J; Wołosowicz, N; Wysocka, J | 1 |
| Czajkowski, A; Dabrowska, M; Gabryelewicz, A; Prokopowicz, J; Wołosowicz, N | 1 |
| Chimura, T; Hirayama, T; Ogawa, T; Shiina, Y | 1 |
| Boughton, BJ; Brown, RM; Harris, RI; Perry, DJ; Rhodes, EG; Welch, RS | 1 |
| Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
| Blaise, D; Carcassonne, Y; Gaspard, MH; Mannoni, P; Maraninchi, D; Miquel, M; Stoppa, AM; Viens, P | 1 |
| Hara, Y; Hisamoto, N; Okamoto, Y; Umeki, S | 1 |
| Ikawa, M; Katoh, M; Yamane, Y | 1 |
| Gall, SA; Gibbs, RS; Hemsell, DL; Knuppel, RA; Lane, TW; Miller, RD; Newton, ER; Poindexter, AN; Reguero, W; Sweet, RL | 1 |
| Boswick, JA; Duma, RJ; Echols, RM; Jemsek, JG; Lerner, R; Lewis, RT; Najem, AZ; Press, RA; Rittenbury, MS; Wilson, SE | 1 |
| Bow, EJ; Louie, TJ | 1 |
| Carlisle, P; D'Olimpio, JT; McKitrick, JC; Miller, M; Sheridan, CA; Wiernik, PH; Wollner, DI | 1 |
| Haga, T; Miyashita, H; Muraoka, A; Nishiya, H; Nozue, N; Ono, Y; Ueda, Y | 1 |
| Bivins, BA; Crots, LD; Fifer, T; Horst, HM; Obeid, FN; Sorensen, VJ | 1 |
| Müller, M; Wittmann, DH | 1 |
| Duff, P | 1 |
| Brister, S; Brown, RA; Chiu, RC; Fradet, G; Mulder, DS; Prentis, J; Richards, GK | 1 |
| Cherubin, CE; Eng, RH | 1 |
| Poindexter, AN; Ritter, M; Sweet, R | 1 |
| De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW | 1 |
| Caplan, ES; Fitzpatrick, BJ; Joshi, M; Tenney, JH; Warren, JW | 1 |
| Anthony, WC; Caplan, ES; Drusano, GL; Henson, A; Joshi, M; Standiford, HC; Tenney, JH; Warren, JW | 1 |
| Appel, KR; Lechner, U; Maier, R; Reuter, W; Wetzel, B; Woitun, E | 1 |
| Baird, I; Bermudez, R; Lorber, B; Noble, R; Silverblatt, F; Vasquez, G; Yangco, BG | 1 |
| Cheng, DL; Liu, CY; Liu, YC; Shi, FW | 1 |
| Srimuang, S; Tanphaichitra, D | 1 |
| Barza, M; Gorbach, SL; Ho, JL; Kellum, JM; O'Donnell, TF; Tally, FP | 1 |
| Fujii, T; Higo, M; Matsuura, Y; Oguma, T; Shimamoto, H; Shimamura, K; Tamura, M; Yamada, H; Yamamoto, M; Yamashina, H | 1 |
| Ma, MY; Rho, JP | 1 |
| Focht, J; Heilmann, HD; Heinrich, S; Klietmann, W | 1 |
| Hayashi, Y; Nakamura, K; Shimada, J | 1 |
| Carey, LC; Fass, RJ; Macynski, ME; Perkins, RL; Plouffe, JF | 1 |
| Bezwoda, WR; Cassel, R; Derman, DP; Perkins, S | 1 |
| Bies, M; Buck, RE; Chisholm, DR; Kessler, RE; Leitner, F; Misiek, M; Price, KE; Pursiano, TA; Tsai, YH | 1 |
| Belch, A; Bow, EJ; Chow, A; Feld, R; Louie, TJ; Mandell, L; Miedzinski, L; Pater, J; Rachlis, A; Robson, HG | 1 |
| Landers, DV; Ohm-Smith, M; Robbie, MO; Sweet, RL | 1 |
| Frommelt, L; Teichmann, W; Wittmann, DH | 1 |
| Follath, F; Mall, T; Reber, H; Ritz, R; Salfinger, M | 1 |
| Jones, RN | 1 |
| Aswapokee, N; Aswapokee, P; Kobwantanakun, S; Pruksachartvutti, S | 1 |
| DeVito, JM; John, JF | 1 |
| Waldvogel, FA | 1 |
| Bansal, MB; Chuah, SK; Lou, MA; Rao, B; See, RC; Thadepalli, H | 1 |
| File, TM; Salstrom, SJ; Tan, JS | 1 |
| Timmes, JJ | 1 |
| Kopp, PE; Siebert, WT | 1 |
| Ruijs, JH | 1 |
9 review(s) available for moxalactam and Bacterial Disease
| Article | Year |
|---|---|
New drug evaluations: moxalactam (Moxam, Eli Lilly).
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Drug Administration Schedule; Humans; Kinetics; Moxalactam | 1982 |
[Review [new antibiotics series IV]: latamoxef (author's transl)].
Topics: Adult; Animals; Bacterial Infections; Cephalosporins; Cephamycins; Child, Preschool; Dogs; Female; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Mice; Moxalactam; Rabbits; Rats | 1982 |
[Pharmacokinetics, in vitro activity and clinical experience with lamoxactam].
Topics: Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Drug Stability; Humans; Kinetics; Moxalactam | 1983 |
Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Blood-Brain Barrier; Cefamandole; Cefotaxime; Cefoxitin; Cephaloridine; Cephalosporins; Cephalothin; Cephamycins; Child, Preschool; Enterobacteriaceae; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Middle Aged; Moxalactam; Pseudomonas aeruginosa | 1981 |
Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
Topics: Bacteria; Bacterial Infections; Bacteroides fragilis; Cefamandole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Humans; Moxalactam; Pseudomonas aeruginosa | 1983 |
Neonatal bacterial infection.
Topics: Antigens; B-Lymphocytes; Bacterial Infections; Chemotaxis, Leukocyte; Complement System Proteins; Cross Infection; Digestive System; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Immunoglobulin G; Immunoglobulin M; Infant, Newborn; Maternal-Fetal Exchange; Meningitis; Methicillin; Moxalactam; Neutrophils; Penicillin G; Permeability; Phagocytosis; Pregnancy; Sepsis; Streptococcal Infections; T-Lymphocytes | 1982 |
[Revaluation of current antimicrobials. Series 16: Latamoxef sodium].
Topics: Adult; Aged; Bacterial Infections; Humans; Methicillin Resistance; Moxalactam; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 1994 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Moxalactam; Penicillins; Postoperative Complications; Pregnancy; Socioeconomic Factors | 1986 |
Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cefotaxime; Ceftazidime; Gram-Positive Bacteria; Humans; Imipenem; Moxalactam; Penicillin Resistance; Penicillins; Streptococcus; Thienamycins | 1985 |
40 trial(s) available for moxalactam and Bacterial Disease
| Article | Year |
|---|---|
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Cephamycins; Child; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Kanamycin; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Prospective Studies; Random Allocation; Ticarcillin | 1982 |
Anaerobic infections in cancer patients--a retrospective analysis of clindamycin, tinidazole, doxycycline, cefoxitin and lamoxactam.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoxitin; Cephamycins; Clindamycin; Clinical Trials as Topic; Doxycycline; Drainage; Female; Humans; Male; Middle Aged; Moxalactam; Neoplasms; Retrospective Studies; Tinidazole | 1982 |
Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Postoperative Complications; Prospective Studies; Random Allocation | 1983 |
Third-generation cephalosporins for polymicrobial surgical sepsis.
Topics: Abscess; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Peritonitis; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1983 |
[Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Clinical Trials as Topic; Escherichia coli Infections; Female; Focal Infection; France; Humans; Male; Moxalactam; Sepsis | 1983 |
[Clinical evaluation of moxalactam].
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Clinical Trials as Topic; Critical Care; Cross Infection; Humans; Meningitis; Moxalactam; Sepsis; Urinary Tract Infections | 1983 |
Hypoprothrombinemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacteroides; Drug Therapy, Combination; Escherichia coli; Feces; Hemorrhagic Disorders; Humans; Hypoprothrombinemias; Intestines; Moxalactam; Neoplasms; Neutropenia; Prothrombin Time; Ticarcillin; Tobramycin | 1984 |
A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Tolerance; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Thienamycins | 1984 |
Clinical evaluation of moxalactam.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Moxalactam; Pneumonia; Sepsis | 1981 |
[Clinical application of 6059-S in the field of obstetrics and gynecology. Effects on gynecological infection and infection of trimester of pregnancy (author's transl)].
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Drug Evaluation; Estriol; Female; Fetal Growth Retardation; Genital Diseases, Female; Humans; Middle Aged; Moxalactam; Placental Function Tests; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Progesterone | 1981 |
Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bacterial Infections; Clavulanic Acids; Drug Combinations; Female; Hallucinations; Humans; Male; Middle Aged; Moxalactam; Penicillins; Piperacillin; Sepsis; Ticarcillin | 1984 |
Imipenem versus moxalactam in the treatment of serious infections.
Topics: Adult; Aged; Bacterial Infections; Female; Humans; Imipenem; Inflammation; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Thienamycins | 1983 |
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin | 1982 |
Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumours.
Topics: Adult; Aged; Antineoplastic Agents; Bacteremia; Bacterial Infections; Ceftriaxone; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Neutropenia; Prospective Studies; Respiratory Tract Infections; Urinary Tract Infections | 1993 |
A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
Topics: Adult; Aged; Bacterial Infections; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Lung Neoplasms; Male; Middle Aged; Moxalactam; Multivariate Analysis; Neutropenia; Random Allocation; Tobramycin; Treatment Outcome | 1991 |
Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?
Topics: Bacterial Infections; Blood Bactericidal Activity; Ceftazidime; Clinical Trials as Topic; Female; Granulocytes; Humans; Male; Middle Aged; Moxalactam; Nitroblue Tetrazolium; Phagocytosis; Random Allocation | 1987 |
Changes in some hemostatic parameters in patients with infections treated with ceftazidime and latamoxef.
Topics: Bacterial Infections; Blood Coagulation Tests; Ceftazidime; Clinical Trials as Topic; Female; Hemostasis; Humans; Male; Middle Aged; Moxalactam; Platelet Count; Random Allocation; Time Factors | 1987 |
Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef.
Topics: Agranulocytosis; Bacterial Infections; Drug Therapy, Combination; Fever; Humans; Immune Tolerance; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Moxalactam; Neutropenia; Prothrombin Time; Random Allocation; Tobramycin | 1987 |
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins | 1988 |
[Randomized trial of empirical antibiotic therapy in febrile episodes after bone marrow transplantation. Comparison of an aminoglycoside-beta lactam (tobramycin-ticarcillin) combination with 2 beta-lactam antibiotics (ticarcillin-latamoxef)].
Topics: Adolescent; Adult; Bacterial Infections; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Moxalactam; Penicillins; Postoperative Complications; Random Allocation; Sepsis; Ticarcillin; Tobramycin | 1988 |
Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections.
Topics: Adult; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Female; Genital Diseases, Female; Humans; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Random Allocation | 1988 |
Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin.
Topics: Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Humans; Moxalactam; Peritonitis; Prospective Studies; Random Allocation; Time Factors | 1988 |
Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection.
Topics: Agranulocytosis; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Humans; Moxalactam; Mycoses; Ticarcillin; Tobramycin | 1987 |
A comparative trial of moxalactam plus ticarcillin and clavulanic acid or piperacillin as empiric antibiotic therapy for febrile cancer patients.
Topics: Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Piperacillin; Ticarcillin | 1987 |
A prospective randomized comparison of a single antibiotic (moxalactam) versus combination therapy (gentamicin and clindamycin) in penetrating abdominal trauma.
Topics: Abdominal Injuries; Adolescent; Adult; Aged; Bacterial Infections; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Wounds, Penetrating | 1988 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Moxalactam; Penicillins; Postoperative Complications; Pregnancy; Socioeconomic Factors | 1986 |
Cefotetan in the treatment of obstetric and gynecologic infections.
Topics: Adult; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Drug Tolerance; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Random Allocation | 1986 |
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation | 1986 |
A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
Topics: Bacterial Infections; Clindamycin; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Tobramycin | 1986 |
Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections.
Topics: Adult; Aged; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Double-Blind Method; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation | 1986 |
Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Cefotaxime; Ceftizoxime; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Random Allocation; Risk | 1987 |
Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Surgical Wound Infection; Tobramycin | 1986 |
Comparison of the effectiveness of moxalactam and cefazolin in the prevention of infection in patients undergoing abdominal operations.
Topics: Abdomen; Adult; Aged; Bacterial Infections; Cefazolin; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Moxalactam; Postoperative Complications; Premedication; Random Allocation | 1985 |
Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Cephalosporins; Cephradine; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neutropenia; Random Allocation; Tobramycin | 1985 |
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Canada; Clinical Trials as Topic; Drug Therapy, Combination; Female; Granulocytes; Humans; Leukemia; Leukocyte Count; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neutropenia; Penicillin Resistance; Prognosis; Random Allocation; Ticarcillin; Tobramycin | 1985 |
Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.
Topics: Adolescent; Adult; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Middle Aged; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Random Allocation; Tobramycin | 1985 |
Ticarcillin plus clavulanic acid versus moxalactam in the treatment of skin and soft tissue infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cellulitis; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Humans; Male; Middle Aged; Moxalactam; Penicillins; Skin Diseases, Infectious; Ticarcillin | 1985 |
Timentin versus moxalactam in the treatment of skin and soft tissue infections.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cellulitis; Clavulanic Acids; Drug Combinations; Female; Humans; Male; Middle Aged; Moxalactam; Penicillins; Skin Diseases, Infectious; Ticarcillin | 1985 |
Comparative study of ticarcillin plus clavulanate potassium and moxalactam in the treatment of surgical infections of the soft tissue.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Evaluation; Female; Humans; Male; Middle Aged; Moxalactam; Penicillins; Surgical Wound Infection; Ticarcillin | 1985 |
Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections.
Topics: Adult; Arthritis, Infectious; Bacterial Infections; Cellulitis; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Humans; Male; Middle Aged; Moxalactam; Osteomyelitis; Penicillins; Skin Diseases, Infectious; Ticarcillin | 1985 |
114 other study(ies) available for moxalactam and Bacterial Disease
| Article | Year |
|---|---|
Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Drug Resistance, Bacterial; Gram-Negative Aerobic Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxalactam; Staphylococcus | 1981 |
Cephalosporin therapy in intraabdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotetan; Cefoxitin; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests; Moxalactam | 1989 |
Single-dose prophylaxis in elective colorectal surgery: a prospective, randomized trial with piperacillin or latamoxef.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Colonic Diseases; Elective Surgical Procedures; Humans; Moxalactam; Piperacillin; Rectal Diseases; Surgical Wound Infection | 1989 |
Activities of two aminoglycosides and five newer beta-lactam antibiotics: safer alternatives to aminoglycosides?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftazidime; Humans; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Tobramycin | 1984 |
Moxalactam in pediatrics.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Kinetics; Meningitis; Moxalactam | 1982 |
Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Citrobacter; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Male; Meningitis; Moxalactam | 1982 |
Clinical experience with Moxalactam in the treatment of pseudomonal and nonpseudomonal infections.
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Male; Middle Aged; Moxalactam; Pseudomonas Infections | 1982 |
Moxalactam in the therapy of serious infections.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Humans; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam | 1982 |
Clinical evaluation of moxalactam.
Topics: Adult; Aged; Anaerobiosis; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam | 1982 |
In vitro combination effects of cefsulodin, moxalactam and cefoperazone with four aminoglycosides on nonfermenting nosocomial gram-negative bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefsulodin; Cephalosporins; Cephamycins; Drug Interactions; Humans; Moxalactam | 1982 |
Comparative inhibitory and bactericidal activities of moxalactam and seven other antibiotics against 520 clinical isolates including 65 multi-drug resistant strains.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Culture Media; Humans; Lactams; Microbial Sensitivity Tests; Moxalactam | 1982 |
Coagulopathy associated with the use of moxalactam.
Topics: Abdomen; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Hypoprothrombinemias; Male; Moxalactam; Vitamin K | 1982 |
Moxalactam in the treatment of pediatric infections.
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Moxalactam | 1982 |
Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children.
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intravenous; Kinetics; Male; Moxalactam | 1982 |
Moxalactam pharmacokinetics in children.
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Moxalactam; Time Factors | 1982 |
Clinical evaluation of moxalactam therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Sepsis | 1982 |
Prolonged bleeding times and bleeding diathesis associated with moxalactam administration.
Topics: Adenosine Diphosphate; Aged; Bacterial Infections; Bleeding Time; Blood Platelets; Cephalosporins; Cephamycins; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; Moxalactam; Platelet Aggregation; Platelet Function Tests | 1983 |
Moxalactam treatment of anaerobic infections in cancer patients.
Topics: Adult; Aged; Anaerobiosis; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Moxalactam; Neoplasms | 1982 |
Hemorrhage, diarrhea, and superinfection associated with the use of moxalactam.
Topics: Aged; Bacterial Infections; Cephalosporins; Cephamycins; Diarrhea; Hemorrhage; Humans; Hypoprothrombinemias; Middle Aged; Moxalactam | 1983 |
[The cerebrospinal fluid concentration of lamoxactam with reference to the therapy of gram-negative CNS infections].
Topics: Adult; Aged; Bacterial Infections; Brain Injuries; Cephalosporins; Cephamycins; Humans; Meningitis; Middle Aged; Moxalactam; Postoperative Complications | 1982 |
Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Child, Preschool; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Moxalactam | 1983 |
Clinical and pharmacokinetic evaluation of moxalactam in infants and children.
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Kidney Function Tests; Kinetics; Liver Function Tests; Male; Moxalactam; Pneumonia; Urinary Tract Infections | 1982 |
[Experience with lamoxactam in gynecology: application as a monotherapeutic agent in severe genital infections and determination of its concentration in uterine and tubal tissues].
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Endometritis; Fallopian Tubes; Female; Genital Diseases, Female; Humans; Middle Aged; Moxalactam; Pelvic Inflammatory Disease; Surgical Wound Infection; Uterus | 1982 |
Treatment of serious infections with moxalactam.
Topics: Abscess; Adult; Ascitic Fluid; Bacterial Infections; Bile; Cephalosporins; Cephamycins; Cerebrospinal Fluid; Escherichia coli; Humans; Moxalactam; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1983 |
In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Humans; Microbial Sensitivity Tests; Moxalactam | 1983 |
[Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Kinetics; Male; Meningitis; Middle Aged; Moxalactam | 1983 |
Moxalactam therapy of bacterial meningitis in adults.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged; Moxalactam | 1983 |
[Laboratory and clinical studies on latamoxef in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Drug Evaluation; Exudates and Transudates; Female; Genital Diseases, Female; Genitalia, Female; Humans; Middle Aged; Moxalactam; Pregnancy | 1983 |
[Clinical experience with moxalactam in the treatment of mixed aerobic-anaerobic surgical infections].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Male; Middle Aged; Moxalactam; Postoperative Complications | 1983 |
Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
Topics: Adolescent; Adult; Aged; Anaerobiosis; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Male; Meningitis; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Sepsis; Urinary Tract Infections | 1983 |
Moxalactam-associated platelet dysfunction.
Topics: Aged; Bacterial Infections; Cephalosporins; Cephamycins; Gastrointestinal Hemorrhage; Humans; Male; Moxalactam; Platelet Aggregation | 1983 |
[Beta-lactams: present status and perspectives].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chemical Phenomena; Chemistry; Humans; Moxalactam; Penicillin Resistance; Penicillins; Terminology as Topic | 1984 |
In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins.
Topics: Bacteria; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Child; Drug Resistance, Microbial; Humans; Moxalactam | 1980 |
In-vitro activity of Sch 29482, MK 0787, ceftriaxone and seven other antimicrobials against 840 separate clinical isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephamycins; Humans; Imipenem; Lactams; Methicillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance | 1982 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
The newest cephalosporins: how to use them?
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Moxalactam | 1982 |
Ceftriaxone--and more to come.
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Child; Humans; Microbial Sensitivity Tests; Moxalactam | 1983 |
[Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Kinetics; Male; Meningitis, Haemophilus; Moxalactam; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1983 |
[The French experience with moxalactam in pneumology].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bronchitis; Bronchopneumonia; Cephalosporins; Cephamycins; Female; France; Humans; Injections, Intramuscular; Male; Middle Aged; Moxalactam; Pneumonia; Respiratory Tract Infections | 1983 |
[Moxalactam in complications of abdominal surgery].
Topics: Abdomen; Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Humans; Middle Aged; Moxalactam; Peritonitis; Postoperative Complications | 1983 |
[Clinical effects of ceftizoxime and latamoxef on infections in acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Ceftizoxime; Drug Evaluation; Female; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Moxalactam; Neutrophils | 1983 |
Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.
Topics: Ampicillin; Animals; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Disease Models, Animal; Gentamicins; Male; Meningitis; Moxalactam; Netilmicin; Rabbits; Species Specificity | 1980 |
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
Topics: Bacterial Infections; Brain Abscess; Cephalosporins; Cephamycins; Escherichia coli Infections; Female; Half-Life; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Parenteral; Injections, Intramuscular; Kinetics; Klebsiella Infections; Male; Meningitis; Moxalactam; Salmonella Infections; Serratia marcescens | 1981 |
Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Bacteroides; Cephalosporins; Cephamycins; Cesarean Section; Drug Evaluation; Enterobacteriaceae; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Moxalactam; Parametritis; Pelvic Inflammatory Disease; Postoperative Complications | 1981 |
Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Moxalactam; Pseudomonas Infections | 1981 |
Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Moxalactam; Osteomyelitis; Pseudomonas aeruginosa; Serratia marcescens; Skin Diseases, Infectious; Urinary Tract Infections | 1981 |
Moxalactam kinetics in hemodialysis.
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Moxalactam; Renal Dialysis | 1981 |
[Clinical studies on 6059-S in the field of pediatrics (author's transl)].
Topics: Acute Disease; Adolescent; Age Factors; Agranulocytosis; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Enteritis; Female; Humans; Infant; Male; Moxalactam; Respiratory Tract Infections; Suppuration; Urinary Tract Infections | 1981 |
[Clinical studies on 6059-S in pediatric field (author's transl)].
Topics: Age Factors; Bacterial Infections; Cephalosporins; Cephamycins; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Moxalactam | 1981 |
[Fundamental and clinical studies in pediatric field on 6059-S (author's transl)].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Parenteral; Injections, Intravenous; Male; Moxalactam | 1981 |
[Basic and clinical examinations of 6059-S in pediatrics (author's transl)].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Male; Moxalactam | 1981 |
[Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
Topics: Adolescent; Age Factors; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Moxalactam | 1981 |
[Clinical evaluation of 6059-S therapy in children (author's transl)].
Topics: Adolescent; Age Factors; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Injections, Intravenous; Male; Moxalactam | 1981 |
[Clinical studies of 6059-S in the field of pediatrics (author's transl)].
Topics: Age Factors; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Moxalactam | 1981 |
[Bacteriological and clinical studies of 6059-S in pediatric infections (author's transl)].
Topics: Adolescent; Age Factors; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Female; Haemophilus influenzae; Humans; Infant; Male; Moxalactam; Penicillin Resistance | 1981 |
[Clinical study on 6059-S in children (author's transl)].
Topics: Age Factors; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Moxalactam | 1981 |
[Experimental and clinical studies on 6059-S (author's transl)].
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Parenteral; Injections, Intravenous; Male; Moxalactam | 1981 |
[Laboratory and clinical studies on 6059-S in children (author's transl)].
Topics: Age Factors; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Moxalactam | 1981 |
[Laboratory and clinical studies of 6059-S in pediatric field (author's transl)].
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Injections, Intravenous; Male; Moxalactam | 1981 |
Moxalactam therapy for a wide spectrum of bacterial infections in adults.
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Moxalactam; Pseudomonas aeruginosa; Staphylococcus; Staphylococcus aureus; Streptococcus | 1981 |
Therapy of lower respiratory tract infections with moxalactam.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cefamandole; Cephalosporins; Cephalothin; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Species Specificity | 1981 |
Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.
Topics: Adult; Bacterial Infections; Cephalosporins; Cephalothin; Cephamycins; Drug Resistance, Microbial; Female; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Moxalactam therapy for bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pseudomonas Infections; Sepsis; Structure-Activity Relationship | 1981 |
Therapeutic approaches to anaerobic infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cefoxitin; Cephamycins; Chloramphenicol; Clindamycin; Drug Combinations; Female; Gastrointestinal Diseases; Genital Diseases, Female; Gram-Negative Anaerobic Bacteria; Humans; Male; Moxalactam; Respiratory Tract Infections; Skin Diseases, Infectious; Suppuration; Ticarcillin | 1981 |
In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam | 1981 |
Moxalactam disodium (Moxam).
Topics: Adult; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Costs and Cost Analysis; Humans; Infant, Newborn; Kinetics; Moxalactam | 1982 |
Use of moxalactam for bacterial meningitis.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Child; Humans; Meningitis; Moxalactam | 1982 |
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacteria, Anaerobic; Bacterial Infections; Child; Drug Evaluation; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Fever; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Piperacillin; Pseudomonas Infections; Random Allocation; Staphylococcal Infections | 1984 |
Moxalactam therapy of serious pediatric infections.
Topics: Bacteria; Bacterial Infections; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Moxalactam; Sepsis | 1984 |
Peritonsillar abscess complicating infectious mononucleosis.
Topics: Adolescent; Adult; Bacterial Infections; Child; Child, Preschool; Female; Humans; Infectious Mononucleosis; Moxalactam; Peritonsillar Abscess; Retrospective Studies | 1984 |
Moxalactam retinal toxicity.
Topics: Animals; Bacterial Infections; Electroretinography; Endophthalmitis; Injections; Microscopy, Electron; Mitochondrial Swelling; Moxalactam; Photoreceptor Cells; Rabbits; Retina; Rod Cell Outer Segment; Vitreous Body | 1984 |
Evaluation of lamoxactam in the treatment of severe bacterial infections.
Topics: Abdomen; Adolescent; Adult; Aged; Bacterial Infections; Female; Humans; Inflammation; Male; Middle Aged; Moxalactam; Osteomyelitis; Phlebitis; Pneumonia; Sepsis; Surgical Wound Infection; Urinary Tract Infections | 1983 |
Hemorrhagic tendency as a complication of Moxalactam therapy in bacterial meningitis.
Topics: Bacterial Infections; Child; Child, Preschool; Hemorrhage; Humans; Male; Meningitis; Moxalactam; Salmonella Infections; Vitamin K | 1983 |
Moxalactam. Evaluation of clinical bleeding in patients with abdominal infection.
Topics: Abdomen; Adult; Aged; Bacterial Infections; Bleeding Time; Evaluation Studies as Topic; Female; Hemorrhage; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Platelet Count; Prospective Studies | 1983 |
Moxalactam therapy of difficult infections in patients with serious underlying conditions.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Moxalactam | 1983 |
[Clinical effect of latamoxef on newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Moxalactam; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis | 1983 |
[Experimental and clinical evaluation of latamoxef in newborn and premature infants].
Topics: Bacterial Infections; Bronchopneumonia; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Infusions, Parenteral; Injections, Intravenous; Male; Moxalactam; Whooping Cough | 1983 |
[Experimental and clinical evaluation of latamoxef in newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Injections, Intravenous; Male; Moxalactam; Premedication | 1983 |
[Experimental and clinical evaluation latamoxef in newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Infusions, Parenteral; Injections, Intravenous; Male; Moxalactam | 1983 |
[Evaluation of latamoxef in neonates].
Topics: Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Male; Moxalactam | 1983 |
[Pharmacokinetic and clinical studies of latamoxef in newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Kinetics; Male; Moxalactam | 1983 |
[Evaluation of latamoxef in the treatment of infections of newborn infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Male; Moxalactam; Pneumonia; Sepsis; Urinary Tract Infections | 1983 |
[Experimental and clinical evaluation of latamoxef in newborn and premature infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Kinetics; Male; Moxalactam | 1983 |
[Clinical application of latamoxef during the perinatal period].
Topics: Adult; Bacterial Infections; Drug Evaluation; Female; Fetal Blood; Humans; Infant, Newborn; Infusions, Parenteral; Injections, Intravenous; Maternal-Fetal Exchange; Moxalactam; Pregnancy; Pregnancy Complications, Infectious | 1983 |
[Experimental and clinical evaluation of latamoxef during the peripaturient period].
Topics: Adult; Amniotic Fluid; Bacterial Infections; Drug Evaluation; Female; Fetal Blood; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Milk, Human; Moxalactam; Pregnancy; Puerperal Infection | 1983 |
[Experimental and clinical studies on latamoxef during the perinatal period].
Topics: Adult; Amniotic Fluid; Bacterial Infections; Drug Evaluation; Female; Fetal Blood; Humans; Infant, Newborn; Kinetics; Maternal-Fetal Exchange; Models, Biological; Moxalactam; Pregnancy; Puerperal Infection | 1983 |
[Clinical evaluation of latamoxef in the perinatal period].
Topics: Amniotic Fluid; Bacterial Infections; Female; Fetal Blood; Humans; Infant, Newborn; Infusions, Parenteral; Maternal-Fetal Exchange; Milk, Human; Moxalactam; Pregnancy; Puerperal Infection; Time Factors | 1983 |
[Experimental and clinical studies on latamoxef in the perinatal period].
Topics: Bacterial Infections; Drug Evaluation; Female; Fetal Blood; Humans; Infant, Newborn; Injections, Intravenous; Kinetics; Maternal-Fetal Exchange; Milk, Human; Moxalactam; Pregnancy; Puerperal Infection; Time Factors | 1983 |
Meningitis.
Topics: Bacterial Infections; Cephalosporins; Humans; Meningitis; Moxalactam; Penicillins | 1984 |
Latamoxef and the newborn.
Topics: Bacterial Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Kinetics; Moxalactam; Prospective Studies | 1984 |
Pharmacokinetic considerations for treatment of bacterial peritonitis during continuous ambulatory peritoneal dialysis.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Female; Fosfomycin; Humans; Male; Middle Aged; Moxalactam; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
[Combination antibacterial effects between aztreonam and eight other antibiotics].
Topics: Amoxicillin; Animals; Aztreonam; Bacterial Infections; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Female; Gentamicins; Mice; Microscopy, Phase-Contrast; Moxalactam; Proteus vulgaris; Pseudomonas aeruginosa; Serratia marcescens | 1991 |
[Effects of prophylactically used latamoxef with tobramycin against postoperative infections on therapeutic drug monitoring and renal function in the field of obstetrics and gynecology].
Topics: Adult; Bacterial Infections; Cesarean Section; Drug Therapy, Combination; Drug Tolerance; Female; Genital Diseases, Female; Humans; Hysterectomy; Infusions, Intravenous; Kidney; Kidney Function Tests; Middle Aged; Moxalactam; Postoperative Complications; Pregnancy; Pregnancy Complications; Premedication; Tobramycin | 1989 |
[Development of Aeromonas hydrophila septicemia in a young healthy woman].
Topics: Adult; Aeromonas; Bacterial Infections; Drug Therapy, Combination; Female; Humans; Moxalactam; Ofloxacin; Oxazines; Sepsis | 1988 |
[Therapeutic bronchoalveolar lavage in pulmonary infections].
Topics: Adult; Aged; Bacterial Infections; Bronchoalveolar Lavage Fluid; Female; Gentamicins; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Therapeutic Irrigation | 1988 |
[Laboratory and clinical studies of flomoxef].
Topics: Adult; Bacteria; Bacterial Infections; Cefazolin; Cefmetazole; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Infusions, Intravenous; Klebsiella; Male; Middle Aged; Moxalactam | 1987 |
Patient stratification in intra-abdominal infection.
Topics: Aged; Bacteria; Bacterial Infections; Cefotetan; Cefuroxime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Peritonitis | 1987 |
Antibiotic prophylaxis in vascular surgery: pharmacokinetic study of four commonly used cephalosporins.
Topics: Animals; Aorta; Bacterial Infections; Cefamandole; Cefazolin; Cefoxitin; Cephalosporins; Dogs; Escherichia coli Infections; Kinetics; Moxalactam; Muscles; Staphylococcal Infections; Time Factors; Tissue Distribution; Vascular Surgical Procedures | 1986 |
Experience with the use of cefotaxime in the treatment of bacterial meningitis.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Klebsiella Infections; Male; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Moxalactam | 1986 |
Synthesis and antimicrobial activity of 7 alpha-methoxypyrimidinyl-ureidocephalosporins.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ceftazidime; Cephalosporins; Mice; Microbial Sensitivity Tests; Moxalactam; Pyrimidines | 1986 |
Penetration of moxalactam into the cerebrospinal fluid and its application in therapy of bacterial meningitis.
Topics: Adult; Aged; Bacterial Infections; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Middle Aged; Moxalactam | 1987 |
In vitro and clinical evaluation of moxalactam.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Female; Humans; Male; Middle Aged; Moxalactam | 1986 |
[The prophylactic effects of latamoxef against the postoperative infections to open heart surgery. Studies on the penetration of latamoxef into the pericardial fluid and the auricle of heart].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Cardiac Surgical Procedures; Female; Heart Valve Prosthesis; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Moxalactam; Myocardium; Postoperative Complications; Surgical Wound Infection | 1986 |
The effect of control on the pattern of utilization of cefotaxime, moxalactam and cefoperazone in a teaching hospital.
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Hospitals, Teaching; Humans; Medical Records; Moxalactam; Pharmacy Service, Hospital; Premedication; Retrospective Studies | 1985 |
A survey of temocillin sensitivity of strains resistant to newer beta-lactam antibiotics.
Topics: Bacterial Infections; Cefotaxime; Humans; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1985 |
Cefmetazole: clinical evaluation of efficacy and safety in Japan.
Topics: Adolescent; Adult; Aged; Aging; Aldehyde Oxidoreductases; Animals; Azoles; Bacterial Infections; Cefmetazole; Cefoperazone; Cephamycins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dogs; Drug Evaluation; Ethanol; Humans; In Vitro Techniques; Infant; Japan; Macaca fascicularis; Male; Middle Aged; Moxalactam; Rats; Rats, Inbred Strains; Respiratory Tract Infections; Structure-Activity Relationship; Tetrazoles | 1985 |
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biological Availability; Blood Proteins; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Male; Mice; Microbial Sensitivity Tests; Moxalactam; Protein Binding | 1985 |
[Significance of the causative agent of infection for therapy of purulent peritonitis].
Topics: Abscess; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Clostridium Infections; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Middle Aged; Moxalactam; Peritonitis | 1985 |
Moxalactam in nosocomial infections with Serratia marcescens.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Moxalactam; Serratia marcescens | 1985 |
Clinical efficacy and safety of a new oxacephem, moxalactam, in serious bacterial infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Moxalactam; Pseudomonas Infections | 1985 |
Effect of formulary restriction of cefotaxime usage.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefoperazone; Cefotaxime; Child; Child, Preschool; Drug Utilization; Female; Formularies, Hospital as Topic; Humans; Infant; Male; Medicine; Middle Aged; Moxalactam; Retrospective Studies; Specialization; Specialties, Surgical | 1985 |
Third generation cephalosporins--a panacea for intensive care patients?
Topics: Bacterial Infections; Cephalosporins; Cross Infection; Humans; Intensive Care Units; Moxalactam | 1985 |
[The combination of ampicillin and gentamycin is not obsolete!].
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Gentamicins; Humans; Infant, Newborn; Meningitis; Moxalactam; Prospective Studies; Random Allocation | 1985 |